Vitamin C in skin care: what the evidence shows for brightening
L-ascorbic acid and its derivatives are among the most studied brightening actives. Here is what recent trials show, how strong the evidence is, and how CSL formulation scientists make it work in a stable product.
By CSL Formulation team · Evidence checked by CSL scientists
At a glance
- What it is
- Vitamin C (L-ascorbic acid) and stable derivatives such as ascorbyl glucoside and magnesium ascorbyl phosphate
- Main benefits
- Brighter, more even-looking tone; antioxidant support; appearance of photoageing
- Levels tested in trials
- 5% to 20% L-ascorbic acid; 28% ascorbyl glucoside complex; 5% magnesium ascorbyl phosphate in a combination
- Time to results
- 8 to 24 weeks in controlled studies
- Watch for
- Oxidation, low-pH irritation, packaging and stability
01What is it?
Vitamin C is the skin’s main water-soluble antioxidant. In cosmetics it is used as pure L-ascorbic acid or as a more stable derivative. The pure form is the best studied but the hardest to keep stable; derivatives are gentler and more stable, but each has its own, usually smaller, evidence base.
02What it does
Vitamin C interrupts melanin production and neutralises free radicals formed by UV exposure. Over months this shows as a brighter, more even-looking tone and, in longer trials, smoother-looking skin in photoaged areas.
03The evidence
Studies below were checked against the publisher, DOI or journal record on 26 Sep 2026. We list design and size so you can judge the strength of each result.
| Study | Design | Who and how long | What it found |
|---|---|---|---|
| Du et al. 2026, Journal of Cosmetic Dermatology Source | Randomised, double-blind, placebo-controlled trial | 71 adults with melasma, 12 weeks, 20% vitamin C with yellow-light treatment | Greater drop in melanin index (−13.1 vs −3.2) and melasma score than placebo; no side effects. The authors call the gain modest. |
| Addor et al. 2026, Dermatology and Therapy (Springer Nature) Source | Open-label study, no control group | 49 women, skin types I–VI, 84 days, 12% L-ascorbic acid serum | Dark-spot intensity −25%, spot size −33%, tone evenness +17%. Weaker evidence because there was no comparison group. |
| Takada et al. 2024, International Journal of Molecular Sciences (MDPI) Source | Double-blind, placebo-controlled half-face study | 27 women with sun spots, 24 weeks, 28% ascorbyl glucoside–arginine complex | Pigmentation fell significantly versus placebo at 12 and 24 weeks, with no skin problems. |
| Barbosa et al. 2024, Clinical, Cosmetic and Investigational Dermatology Source | Randomised, double-blind trial against 4% hydroquinone | 50 women with melasma, 60 days, 5% magnesium ascorbyl phosphate with 10% niacinamide | Melasma score fell 32% versus 43% with hydroquinone; not significantly different, and no serious side effects. |
| Correia and Magina 2023, Journal of Cosmetic Dermatology Source | Systematic review of randomised trials | 7 publications, 139 volunteers | Objective lightening of treated areas, but long-term use is needed and the ideal concentration is not yet established. |
| Espinal-Perez et al. 2004, International Journal of Dermatology Source | Double-blind, randomised split-face trial | 16 women with melasma, 16 weeks, 5% ascorbic acid vs 4% hydroquinone | Hydroquinone scored better subjectively (93% vs 62.5% good-to-excellent) but side effects were 68.7% vs 6.2% with vitamin C. |
| Humbert et al. 2003, Experimental Dermatology Source | Double-blind, placebo-controlled trial | Photoaged neck and forearm skin, 6 months, 5% vitamin C cream | Significant improvement versus placebo, with fewer deep furrows and signs of elastic-tissue repair. |
Vitamin C reliably brightens and evens tone, but gains are steady rather than dramatic and need months of daily use. It is far gentler than hydroquinone, which makes it a strong everyday brightening active.
04How CSL formulation scientists use it
- Pure L-ascorbic acid must be formulated below pH 3.5 to penetrate skin (Pinnell 2001); skin levels saturate after about three daily applications.
- Choose the form to match the product: pure vitamin C for high-performance serums, derivatives for gentler, more stable formats. Claim only what the form you use has been tested for.
- Protect it from oxygen and light: airless or opaque packs, antioxidant partners and real-time stability testing.
- Vitamin C works well alongside niacinamide and tranexamic acid, which act at different steps of pigmentation.
05Regulatory and claims
Ascorbic acid and its common derivatives are widely permitted in cosmetics. CSL regulatory specialists confirm each market’s status for the exact derivative before a formula is finalised, and keep claims to the cosmetic wording: “brighter, more even-looking skin”, not “treats melasma”.
06Questions brands ask
Is a higher percentage always better?
No. Trials show benefits from 5% upward, and higher strengths raise irritation and stability problems. The right level depends on the form, pH and product.
Do vitamin C derivatives work?
Some do, at the levels tested. A 28% ascorbyl glucoside complex reduced sun spots over 24 weeks in a controlled study. Evidence for other derivatives is thinner.
Can vitamin C be combined with niacinamide?
Yes. Several recent trials use them together, and modern formulas combine them without problems.
07References
- Du D, et al. Yellow light monotherapy versus yellow light combined with 20% vitamin C for melasma. J Cosmet Dermatol. 2026;25(9). doi.org/10.1111/jocd.71146
- Addor FAS, et al. Clinical efficacy of a 12% pure vitamin C serum across all skin phototypes. Dermatol Ther. 2026;16. doi.org/10.1007/s13555-026-01862-3
- Takada M, et al. Treatment with ascorbyl glucoside–arginine complex ameliorates solar lentigos. Int J Mol Sci. 2024;25(24):13453. doi.org/10.3390/ijms252413453
- Barbosa MMC, et al. Nicotinamide 10% with magnesium ascorbyl phosphate 5% and hyaluronic acid 5% vs hydroquinone 4% in facial melasma. Clin Cosmet Investig Dermatol. 2024;17:2215–2223. doi.org/10.2147/CCID.S473224
- Correia G, Magina S. Efficacy of topical vitamin C in melasma and photoaging: a systematic review. J Cosmet Dermatol. 2023;22(7):1938–1945. doi.org/10.1111/jocd.15748
- Espinal-Perez LE, et al. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Int J Dermatol. 2004;43(8):604–607. doi.org/10.1111/j.1365-4632.2004.02134.x
- Humbert PG, et al. Topical ascorbic acid on photoaged skin. Exp Dermatol. 2003;12(3):237–244. doi.org/10.1034/j.1600-0625.2003.00008.x
- Pinnell SR, et al. Topical L-ascorbic acid: percutaneous absorption studies. Dermatol Surg. 2001;27(2):137–142. doi.org/10.1046/j.1524-4725.2001.00264.x
Used in: Brightening & radianceHyperpigmentation & even toneAnti-ageing & wrinkles
Update log
- Evidence reviewed and page published by CSL scientists
This page summarises published research for brands and formulators. It is general information, not medical advice, and results in studies depend on the full formula tested.
